Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia

American Journal of Hematology

Volumn 53, Issue 3, 1996, Pages 175-180

  Fruchart, Christophe ^a   Lenormand, Bernard ^b   Bastard, Christian ^b   Boulet, Dominique ^b   Lesesve, Jean François ^b   Callat, Marie Paule ^b   Stamatoullas, Aspasia ^b   Monconduit, Mathieu ^b   Tilly, Hervé ^b  

^a CENTRE HENRI BECQUEREL   (France)

^b NONE

Author keywords

Acute myeloid leukemia; CD34 antigen; Chromosomal abnormalities

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CD34 ANTIGEN; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; LIFE TABLES; MALE; MIDDLE AGED; MONOSOMY; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR STEM CELLS;

EID: 0029909996     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199611)53:3<175::AID-AJH5>3.0.CO;2-W     Document Type: Article

References (29)

1. Borowitz MJ, Glokerman JP, Moore JO, Civin CL, Page SO, Bigner SH: Clinicopathologic and cytogenetic features of CD34 (My10) positive acute nonlymphocytic leukemia. Am J Clin Pathol 91:265, 1989.
2. Geller RB, Zahurak M, Hurwitz CA, Burke PJ, Karp JE, Civin CL: Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia: The significance of the stem-cell glycoprotein CD34 (My10). Br J Haematol 76:340, 1990.
3. Guinot M, Sanz GF, Sempere A, Arilla J, Jarque I, Sanz MA: Prognostic value of CD34 expression in de novo acute myeloblastic leukemia. Br J Haematol 79:533, 1991.
4. Fagioli F, Cueno A, Carli MG, Bardi MG, Piva N, Castoldi G: Chromosome aberrations in CD34-positive acute myeloid leukemia. Cancer Genet Cytogenet 71:119, 1993.
5. Katz FR, Tindle RW, Suthelands DR, Greaves MF: Identification of a membrane glycoprotein associated with hemopoietic progenitor cells. Leuk Res 9:191, 1985.
6. Selleri C, Notaro R, Catalano L, Fontana R, Del Vecchio L, Rotoli B: Prognostic irrelevance of CD34 in acute myeloid leukemia. Br J Haematol 82:479, 1992.
7. Ciolli S, Leoni F, Caporale R, Pascarella A, Salti F, Rossi-Ferrini P: CD34 expression fails to predict the outcome in adult myeloid leukemia. Haematologica 78:420, 1993.
8. Wood P, Burgess R, Mac-Gregor A, Yin JA: P-glycoprotein expression on acute myeloid leukemia blast cells at diagnosis predicts response to chemotherapy and survival. Br J Haematol 87:509, 1994.
9. Bennet JM, Catorsky D, Daniel MT, Flandrin G, Galton DAG, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia: A report of the Frensh-American-British Cooperative group. Ann Intern Med 103:620, 1985.
10. Sehested J: A simple method for R banding of human chromosomes showing a pH dependent connection R and G bands. Human Genet 21:55, 1974.
11. ISCN. Harnden DE, Kingler HP (eds): "An International System for Human Cytogenetic Nomenclature." Basel, Switzerland: Karger, 1985.
12. Armitage P: "Statistical Methods in Medical Research." New York: John Wiley, 1971.
13. Kaplan EL, Meier P: Non parametric estimation from incomplete observation. J Am Stat Assoc 53:457, 1958.
14. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966.
15. Stasi R, Del poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G: Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-MO). Blood 83:1619, 1994.
16. Tsunoda S, Yoshida M: Diagnosis and treatment of acute undifferentiated leukemia and AML-MO. Jpn J Clin Mematol 35:238, 1994.
17. Solary E, Casanovas RA, Campos L, Bene MC, Faure G, Maingnon P, Falkenrdt A, Lenormand B, Genetet N: Surface markers in adult acute myeloblastic leukemia: Correlation of CD19+, CD34+ and CD14+/DR phenotypes with shorter survival. Groupe d'etude immunologique des leucémies (GEIL). Leukemia 6:393, 1992.
18. Vaughan WP, Civin CL, Weisenburger DD, Karp JE, Graham ML, Burke PJ: Acute leukemia expressing the normal human hemopoietic stem cell membrane glycoprotein (My10). Leukemia 2:661, 1988.
19. Whang Peng J, Young RC, Lee EC, Longo DL, Schechter GP, Devita VT: Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 71:403, 1988.
20. Pedersen J, Philip P, Larsen SO, Jensen G, Byrsting K: Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 76:1083, 1990.
21. Michels SD, McKenna RW, Arthur DC, Brunning RD: Therapy related acute myeloid leukemia and myelodisplastic syndrome. A clinical and morphologic study of 65 cases. Blood 65:1364, 1985.
22. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N: Phenotypical characteristics of acute leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80:470, 1992.
23. Yunis JJ, Bruning RD, Howe RB, Lobell M: High resolution chromosomes as an independent prognostic indicator in adult acute non lymphocytic leukemia. New Engl J Med 311:812, 1984.
24. Swirsky DM, Li YS, Mattews JG, Flemans RJ, Rees KH, Hayhoe FGJ: 8;21 translocation in acute granulocytic leukemia: Cytological, cytochemical and clinical features. Br J Haematol 56:199, 1984.
25. Groupe Français de Cytogénétique Hématologique: Acute myelogenous leukemia with an 8;21 translocation: A report on 148 cases from the Groupe Français de Cytogénétique Hématologique. Cancer Genet Cytogenet 44:169, 1990.
26. Berger R, Berheim A, Daniel MT, Valensi F, Sigaux F, Flandrin G: Cytologic characterization and significance of normal karyotypes in t(8;21) acute myeloblastic leukemia. Blood 59:199, 1984.
27. Keating MJ, Cork A, Broach Y, Smith T, Walter RS, Mc-Credie KB, Trujillo J, Freireich EJ: Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leuk Res 11:119, 1987.
28. Berger R, Berheim A, Ochoa-noguera ME, Daniel MT, Valensi F, Sigaux F, Flandrin G, Boiron M: Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: A study of 343 patients. Cancer Genet Cytogenet 28:293, 1987.
29. Schiffer CA, Lee EJ, Tomiyasu T, Wiermick PH, Testa JR: Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 73:263, 1989.